Peptides
L-Carnitine (Injectable)
Also called Levocarnitine · Carnitine
Injectable L-carnitine is discussed for fat loss, workout pumps and performance. It helps the body handle fatty acids, but that role does not mean an injection automatically burns body fat. The approved IV medicine treats specific deficiency situations; bodybuilding use is a different context.
Dosage & duration
One reported bodybuilding use, not a validated fat-loss regimen.
One reported bodybuilding use
Reported use · unapproved regimen- Dose
- 500 mg by IM injection
- How often
- Daily
- How long
- Cutting/maintenance period; no fixed endpoint stated
The author also used anabolic steroids. This is one report, not a typical or proven-safe range.
Fat loss and workout claims
A better pump does not measure fat loss
Carnitine’s role in handling fatty acids does not establish that an injection produces a leaner physique.
-
Workout sensation
Pumps and how a session feels are different from a change in body fat.
-
Before-and-after photos
Diet, training and other drugs can contribute; a visible change cannot isolate carnitine’s effect.
-
The route matters
The prescription IV product treats specific deficiency situations. That label does not validate a bodybuilding injection plan.
Why lifters consider it
Public discussions focus on a leaner look, workout pumps and whether injections work better than oral supplements. Those are distinct outcomes, and a good workout sensation is not proof of fat loss.
What reports leave out
The named community example also involved anabolic steroids. Diet, training and other drugs make it impossible to assign the visible result to carnitine alone. Oral studies and medically supervised IV studies do not validate every IM or subcutaneous protocol.
Route is part of the dose
Prescription levocarnitine injection is an IV product with indication-specific dosing. Its label should not be repurposed as a performance-injection plan, and injection-site tolerability is not proof of product quality.
Model details: L-Carnitine (Injectable) · relative timing
Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.
Shows a relative timing scenario; absolute blood concentrations are not calibrated.
Timing assumptions and sources
Label apparent terminal half-life of 17.4 h is from uncorrected plasma after 20 mg/kg IV over 3 min; distribution half-life is 0.585 h. Endogenous baseline affects the terminal estimate. This is not a verified IM/SC tail.
One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.
- Timing half-life used
- 17.4 hours
- Absorption half-life assumed
- 4.35 hours
- Reference amount for the relative scale
- 1 mg
- Absorption half-life is assumed to be one quarter of the slower timescale (4.35 h); it is not a measured absorption parameter.
- A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
- Do not borrow an oral steady-state peak for injection.
- Label clearance of 4 L/h and terminal 17.4 h include baseline and do not suffice for an exogenous-only model.
- The SC/IM 70% availability assumption is unsupported.
- Levocarnitine injection label, Pharmacokinetics
The 20 mg/kg IV study used a two-compartment model and uncorrected endogenous plasma levels. Its half-lives were 0.585 h and 17.4 h. The separate 80 µmol/L peak after four days of oral 2 g twice daily is not an injectable Cmax.
l-carnitine-relative-timing-2026-10 · version 1
Common questions
Does injectable carnitine melt fat at the injection site?
The cited evidence does not establish local spot-fat loss.
Is the injection dose the same as an oral supplement dose?
No. Absorption and formulation differ; one route cannot be converted into the other using a simple ratio.
Sources Labels, studies and notes behind this guide
Catalog evidence: Other human research. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Main interest
- Different goals; neither follows automatically from higher blood carnitine.
- Important difference
- Route and reason for use change the meaning of a dose.
- 1. DailyMed: levocarnitine injection label
200 mg/mL IV preparation for specific secondary deficiency and dialysis contexts. Two-compartment IV profile; apparent terminal half-life 17.4 h from values uncorrected for endogenous carnitine; oral availability around 15%.
- 2. Villani et al.: carnitine and exercise trial
Eight-week oral supplementation plus walking study in overweight women did not significantly change body mass or fat mass. One population and oral route, not proof that all carnitine studies are negative.
- 3. Levocarnitine injection label, Pharmacokinetics
The 20 mg/kg IV study used a two-compartment model and uncorrected endogenous plasma levels. Its half-lives were 0.585 h and 17.4 h. The separate 80 µmol/L peak after four days of oral 2 g twice daily is not an injectable Cmax.
Related compounds and examples
Related compounds
NAD+ (Nicotinamide Adenine Dinucleotide)
NAD+ infusions are marketed for energy, clearer thinking and healthy aging. Human studies have measured changes in NAD-related blood markers, but that is not the same as proving a lasting improvement in energy or reversing aging. Time, cost and infusion tolerability are practical considerations.
Semaglutide Injection (Ozempic/Wegovy)
Semaglutide can reduce hunger and food intake, helping people lose weight. Wegovy injections are prescribed for weight management; Ozempic injections treat type 2 diabetes. Both are taken weekly, with gradual dose increases to help manage digestive side effects.
Semaglutide Oral (Rybelsus)
Oral semaglutide offers a daily tablet option for adults with type 2 diabetes who want to avoid injections. The morning routine matters: food, drink and other tablets affect absorption, and different semaglutide products cannot be compared milligram for milligram.